millennium pharmaceuticals inc. Resources | BNET
On GameSpot: Wii Fit tells 10-year-old she's fat

BNET Industries

Millennium Pharmaceuticals Inc.

(MLNM) is in the Pharma Industry

millennium pharmaceuticals inc. - All News and Analysis

  • Revenue (Fiscal Year) $527.5M
  • Profit (Fiscal Year) $14.9M
  • Market Cap $8.1B
  • Incorporated: 1993
  • CEO: Dr. Deborah Dunsire M.D.

Millennium Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing medicines to improve the lives of patients with cancer, inflammatory bowel diseases and other inflammatory diseases. Co.'s VELCADE® (bortezomib) product for Injection, is marketed for the treatment of patients with multiple myeloma who have received at least one prior therapy and for the treatment of Mantle Cell Lymphoma, or MCL, patients who have received at least one prior therapy. Co. distributes VELCADE in the U.S. through a sole-source open access distribution model where Co. sells directly to an independent third party who in turn distributes to the wholesaler base.

Stock Quote

Board of Directors

Mr. Kenneth E. Weg Chairman

Dr. Jeffrey M. Leiden M.D., Ph

Mr. A. Grant Heidrich III Vice-Chairman

Dr. Anthony H. Wild Ph.D.

Mr. Mark J. Levin

Dr. Charles J. Homcy M.D.

Dr. Raju S. Kucherlapati Ph.D.

Mr. Norman C. Selby

Dr. Deborah Dunsire M.D.

Mr. Robert F. Friel

Contact Information

40 Landsdowne Street

Cambridge, MA

http://www.mlnm.com

617 679-7000

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412